VRCHIVMAB0115-00-AB (VRC01.23LS)

VRC01.23LS · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRCHIVMAB0115-00-AB (VRC01.23LS), covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRCHIVMAB0115-00-AB (VRC01.23LS), Administered Intravenously or Subcutaneously to Healthy Adults [Phase 1]

See pricing